Engelhard H H
Department of Neurosurgery, The University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Surg Neurol. 2001 Feb;55(2):89-101. doi: 10.1016/s0090-3019(01)00349-4.
The clinical management of patients with meningiomas has changed over the past decade. Change has occurred because of a variety of factors including improved diagnostic imaging, better results with surgery and interventional neuroradiology, and the advent of radiosurgery. Recent clinical studies from several disciplines have provided new information on topics germane to the management of patients with meningiomas. Collecting this information into a series of review articles would have significant value, primarily for neurosurgeons.
The purpose of this first paper is to bring together and evaluate the available data on: 1) noninvasive diagnostic imaging of meningiomas, including magnetic resonance imaging (MRI), computed tomography (CT) scanning, and MR angiography, venography and spectroscopy; 2) the present role of cerebral angiography in patients with meningiomas; and 3) the current status of preoperative embolization for these tumors.
With the advent of MR technology, the quality of diagnostic imaging for meningiomas has improved dramatically, and this is reflected in more sophisticated preoperative planning. MR imaging provides improved delineation of dura and sinus involvement, and even information about a tumor's consistency. Meningiomas have characteristic neuroimaging features, yet other lesions can still mimic a meningioma. MR venography can be used to demonstrate sinus patency, but intra-arterial cerebral angiography gives the most precise information concerning the degree of tumor involvement of critical vascular structures, and the anatomy of arterial feeders. In trained hands, superselective catheterization for preoperative embolization of meningiomas is feasible, and seems to be reasonably safe.
MR imaging, CT scans, and cerebral angiography can currently be used in a complementary fashion to diagnose, evaluate, and treat patients with meningiomas, with a high degree of clinical certainty. Angiography is used to determine the sites of blood supply to the tumor, which can then be attacked first intraoperatively, making tumor removal easier. Preoperative embolization continues to have value in selected patients, including those in whom the blood supply to the tumor is difficult to access at the time of surgery.
在过去十年中,脑膜瘤患者的临床管理发生了变化。这种变化是由多种因素引起的,包括诊断成像的改善、手术和介入神经放射学取得更好的效果以及放射外科的出现。来自多个学科的近期临床研究提供了与脑膜瘤患者管理相关主题的新信息。将这些信息收集成一系列综述文章将具有重要价值,主要对神经外科医生而言。
第一篇论文的目的是汇集并评估关于以下方面的现有数据:1)脑膜瘤的非侵入性诊断成像,包括磁共振成像(MRI)、计算机断层扫描(CT)、磁共振血管造影、静脉造影和波谱分析;2)脑血管造影在脑膜瘤患者中的当前作用;3)这些肿瘤术前栓塞的现状。
随着磁共振技术的出现,脑膜瘤的诊断成像质量有了显著提高,这反映在更精细的术前规划中。磁共振成像能更好地描绘硬脑膜和窦的受累情况,甚至能提供有关肿瘤质地的信息。脑膜瘤具有特征性的神经影像学表现,但其他病变仍可能模仿脑膜瘤。磁共振静脉造影可用于显示窦的通畅情况,但动脉内脑血管造影能提供关于关键血管结构的肿瘤累及程度以及供血动脉解剖结构的最精确信息。在经验丰富者手中,对脑膜瘤进行术前栓塞的超选择性导管插入术是可行的,且似乎相当安全。
目前,磁共振成像、CT扫描和脑血管造影可相互补充用于诊断、评估和治疗脑膜瘤患者,临床确定性较高。血管造影用于确定肿瘤的供血部位,然后可在术中首先处理,使肿瘤切除更容易。术前栓塞在特定患者中仍有价值,包括那些手术时肿瘤供血难以触及的患者。